icon-    folder.gif   Conference Reports for NATAP  
 
  Fatty Liver Disease

 
 
 
 
Fatty Liver, NAFLD, NASH Definitions
 
 
  CROI: FATTY LIVER DISEASE: A GROWING CONCERN - - (04/12/17) a plenary talk by noted fatty liver expert Rohit Loomba from UCSD
 
CROI: Changes in Liver Fibrosis and Steatosis in HIV Mono-Infected patients over 24 months - 50% have fatty liver at average age of 46 - (03/28/17)
 
CROI: LIVER STEATOSIS AND FIBROSIS IN AT-RISK EUROPEAN HIV-MONOINFECTED PATIENTS - 64% with steatosis among those who had elevated LFTs and/or metabolic syndrome and/or lipodystrophy - (03/28/17)
 
Definition & Facts of NAFLD & NASH
 

NIH

What is NAFLD?
 
Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. This buildup of fat is not caused by heavy alcohol use. When heavy alcohol use causes fat to build up in the liver, this condition is called alcoholic liver disease . Two types of NAFLD are simple fatty liver and nonalcoholic steatohepatitis (NASH). Simple fatty liver and NASH are two separate conditions. People typically develop one type of NAFLD or the other, although sometimes people with one form are later diagnosed with the other form of NAFLD.
 
Simple fatty liver
 
Simple fatty liver, also called nonalcoholic fatty liver (NAFL), is a form of NAFLD in which you have fat in your liver but little or no inflammation or liver cell damage. Simple fatty liver typically does not progress to cause liver damage or complications.
 
NASH
 
NASH is a form of NAFLD in which you have inflammation and liver cell damage, in addition to fat in your liver. Inflammation and liver cell damage can cause fibrosis, or scarring, of the liver. NASH may lead to cirrhosis or liver cancer .
 
Experts are not sure why some people with NAFLD have NASH while others have simple fatty liver.
 
How common are NAFLD and NASH?
 
NAFLD is one of the most common causes of liver disease in the United States. Most people with NAFLD have simple fatty liver. Only a small number of people with NAFLD have NASH. Experts estimate that about 20 percent of people with NAFLD have NASH.1 Between 30 and 40 percent of adults in the United States have NAFLD. About 3 to 12 percent of adults in the United States have NASH.1
 
Who is more likely to develop NAFLD?
 
NAFLD is more common in people who have certain conditions, including obesity and conditions that may be related to obesity, such as type 2 diabetes. Researchers have found NAFLD in 40 to 80 percent of people who have type 2 diabetes and in 30 to 90 percent of people who are obese.2 In research that tested for NAFLD in people who were severely obese and undergoing bariatric surgery, more than 90 percent of the people studied had NAFLD.3 NAFLD can affect people of any age, including children. Research suggests that close to 10 percent of U.S. children ages 2 to 19 have NAFLD.4 However, people are more likely to develop NAFLD as they age.
 
While NAFLD occurs in people of all races and ethnicities, it is most common in Hispanics, followed by non-Hispanic whites.2 NAFLD is less common in African Americans.2 Asian Americans are more likely than people of other racial or ethnic groups to develop NAFLD when their weight is within the normal range.5
 
What are the complications of NAFLD and NASH?
 
The majority of people with NAFLD have simple fatty liver, and people with simple fatty liver typically don't develop complications.1
 
NASH can lead to complications, such as cirrhosis and liver cancer. People with NASH have an increased chance of dying from liver-related causes.3
 
If NASH leads to cirrhosis, and cirrhosis leads to liver failure, you may need a liver transplant to survive.
 
Studies also suggest that people with NAFLD have a greater chance of developing cardiovascular disease. Cardiovascular disease is the most common cause of death in people who have either form of NAFLD.6
 
References
 
[1] Spengler EK, Loomba R. Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clinic Proceedings. 2015;90(9):1233-1246.
 
[2] Brunt EM, Wong VW, Nobili V, et al. Nonalcoholic fatty liver disease. Nature Reviews Disease Primers. 2015;1:15080
 
[3] Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-2023.
 
[4] Fussilo S, Rudolph B. Nonalcoholic fatty liver disease. Pediatrics in Review. 2015;36(5):198-206.
 
[5] Sears D. Fatty Liver. Medscape website. emedicine.medscape.com . Updated December 14, 2014. Accessed October 7, 2015.
 
[6] Azzam H, Malnick S. Non-alcoholic fatty liver disease-the heart of the matter. World Journal of Hepatology. 2015;7(10)1369-1376. November 2016